Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ENROLLING BY INVITATION
NCT07662902

Ulcerative Colitis Permeability

Sponsor: University Hospital Dubrava

View on ClinicalTrials.gov

Summary

Study aim: To investigate whether the values of zonulin and lipopolysaccharide-binding protein (LBP) as biomarkers of intestinal permeability are related to the degree of liver steatosis, steatohepatitis and fibrosis in patients with ulcerative colitis (UC) and metabolic-associated steatotic liver disease (MASLD). Subjects and methods: Participants with UC will be included, except for those whose inflammation affects only the rectum. During the clinical and biochemical remission of UC, a physical examination, taking of anamnestic data, blood tests, and abdominal ultrasound with measurement of parameters of liver steatosis, steatohepatitis, and fibrosis (controlled attenuation parameter, FibroScan-AST score, liver stiffness measure) will be performed via transient elastography. Blood samples will be taken to determine zonulin and LBP, and statistical data will be processed. Expected contribution to the field: Indicate the potential of zonulin and LBP as markers for advanced liver fibrosis in patients with MASLD and UC.

Official title: Association Between Zonulin and Lipopolysaccharide-binding Protein as Biomarkers of Intestinal Permeability and Hepatic Steatosis in Patients With Ulcerative Colitis

Key Details

Gender

All

Age Range

18 Years - 70 Years

Study Type

OBSERVATIONAL

Enrollment

100

Start Date

2025-12-01

Completion Date

2027-05

Last Updated

2026-06-25

Healthy Volunteers

No

Locations (1)

University Hospital Dubrava

Zagreb, Croatia